Tuesday, July 12, 2022

Colaboration with Czech Association of Pharmaceutical Companies

Aleš Šima

Head of Business Development

oncomed participated in a discussion with the Ministry of Health and the Ministry of Industry and Trade of the Czech Republic on the support and future of domestic drug production.

The professional round table discussion took place with the contribution and active participation of member companies of the Czech Association of Pharmaceutical Companies that have production plants in the Czech Republic. The main partners in the round table discussion were oncomed, Teva and Zentiva.

We contributed to the program by presenting a case study of the introduction of the production of a new generic drug with a focus on the main milestones and project budget, and we also presented the possibilities of vaccine production in the Czech Republic.

Pharmaceutical production in Europe and the Czech Republic has high added value and great potential for the future. We believe that our active contributions to the discussion have contributed to the future support and expansion of the domestic pharmaceutical industry.

17. 12. 2024 | News

PF 2025

read text
12. 12. 2024 | Articles

Strengthening pharmaceutical self-sufficiency in the Czech Republic: A path to healthcare security

In recent years, pharmaceutical self-sufficiency has become a pressing issue for the Czech Republic, and indeed for all of Europe.
read text
15. 11. 2024 | Articles News

We published 2023 ESG report

We are pleased to announce that we have successfully completed and released our 2023 ESG report.
read text